These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22609845)

  • 21. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
    Anderlini P; Giralt S; Andersson B; Ueno NT; Khouri I; Acholonu S; Cohen A; Körbling MJ; Manning J; Romaguera J; Sarris A; Rodriguez ; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin RE
    Bone Marrow Transplant; 2000 Sep; 26(6):615-20. PubMed ID: 11041566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
    Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M
    Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.
    Fuji S; Kim SW; Yano S; Hagiwara S; Nakamae H; Hidaka M; Ito T; Ohashi K; Hatanaka K; Takami A; Kurosawa S; Yamashita T; Yamaguchi T; Fukuda T
    Bone Marrow Transplant; 2016 Mar; 51(3):451-3. PubMed ID: 26551777
    [No Abstract]   [Full Text] [Related]  

  • 25. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation for severe aplastic anemia in Japan.
    Kanamaru A; Nagai K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
    Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
    Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of aplastic anaemia: first do no harm.
    Marsh JC
    Lancet; 2000 Nov; 356(9241):1536-7. PubMed ID: 11075760
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.
    Deeg HJ; Anasetti C; Petersdorf E; Storb R; Doney K; Hansen JA; Sanders J; Sullivan KM; Appelbaum FR
    Blood; 1994 Jun; 83(11):3417-8. PubMed ID: 8193380
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.
    Anderlini P; Acholonu SA; Okoroji GJ; Bassett RE; Shpall EJ; Qazilbash MH; Popat UR; Worth LL; Giralt SA; Champlin RE
    Leuk Lymphoma; 2011 Jan; 52(1):137-41. PubMed ID: 20939697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
    Kharfan-Dabaja MA; Otrock ZK; Bacigalupo A; Mahfouz RA; Geara F; Bazarbachi A
    Bone Marrow Transplant; 2012 Sep; 47(9):1254-5. PubMed ID: 22246089
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
    Ambulkar I; Parikh PM; Saikia T
    J Assoc Physicians India; 2003 Jul; 51():715-6. PubMed ID: 14621044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning?
    Kudo K; Muramatsu H; Narita A; Yoshida N; Kobayashi R; Yabe H; Endo M; Inoue M; Hara J; Kounami S; Inagaki J; Hashii Y; Kato K; Tabuchi K; Kojima S
    Bone Marrow Transplant; 2017 Dec; 52(12):1659-1661. PubMed ID: 28783143
    [No Abstract]   [Full Text] [Related]  

  • 39. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
    Gupta V; Ball SE; Sage D; Ortin M; Freires M; Gordon-Smith EC; Marsh JC
    Bone Marrow Transplant; 2005 Mar; 35(5):467-71. PubMed ID: 15665848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful pregnancy after high dose chemotherapy and marrow transplantation for treatment of aplastic anemia.
    Card RT; Holmes IH; Sugarman RG; Storb R; Thomas ED
    Exp Hematol; 1980 Jan; 8(1):57-60. PubMed ID: 6997062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.